⏳ Fetching live dividend data...
Home › Calculator › ESALY Dividend Calculator 2026
Eisai Co., Ltd. · OTC
Price: $61.51 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
ESALY is not a dividend-focused stock
ESALY pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Eisai Co., Ltd. (ESALY) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2022-09-28Latest | — | $0.5703 | 2.99% | $40.13 |
| 2022-03-29 | — | $0.6280 | 2.70% | $49.13 |
| 2021-09-28 | — | $0.6981 | — | — |
| 2021-03-29 | — | $0.7332 | — | — |
| 2020-09-28 | — | $0.7686 | — | — |
| 2020-03-27 | — | $0.7429 | — | — |
| 2019-09-26 | — | $0.7358 | — | — |
| 2019-03-27 | — | $0.7416 | — | — |
| 2018-09-26 | — | $0.6205 | — | — |
| 2018-03-28 | — | $0.7323 | — | — |
| 2017-09-27 | — | $0.6149 | — | — |
| 2017-03-28 | — | $0.7047 | — | — |
| 2016-09-27 | — | $0.6315 | — | — |
| 2016-03-24 | — | $0.7301 | — | — |
| 2015-09-25 | — | $0.5656 | — | — |
| 2015-03-26 | — | $0.6682 | — | — |
| 2014-09-26 | — | $0.6006 | — | — |
| 2014-03-26 | — | $0.7856 | — | — |
| 2013-09-25 | — | $0.8076 | — | — |
| 2013-03-26 | — | $0.9000 | — | — |
| 2012-09-25 | — | $1.0801 | — | — |
| 2012-03-27 | — | $1.0058 | — | — |
| 2011-09-27 | — | $1.1422 | — | — |
| 2011-03-28 | — | $1.1333 | — | — |
| 2010-09-27 | — | $0.9757 | — | — |
| 2010-03-28 | — | $1.1103 | — | — |
Headquartered in Tokyo, Japan, Eisai Co., Ltd. is a pharmaceutical company that develops and markets a diverse range of medicinal products within Japan. Its extensive product lineup includes treatments for neurological conditions, such as Aricept for Alzheimer's disease and Lewy body dementia, Methycobal for peripheral neuropathy, and Fycompa, an antiepileptic drug for specific partial-onset and generalized tonic-clonic seizures. Eisai also offers Dayvigo, an anti-insomnia agent for adults. In the field of oncology, the company provides Lenvima, a molecularly targeted anticancer agent for thyroid cancer, renal cell carcinoma (in combination with everolimus), and hepatocellular carcinoma, alongside Halaven, a microtubule dynamics inhibitor used for breast cancer and liposarcoma. Other key pharmaceuticals include Lyrica for pain management, and Pariet, a proton-pump inhibitor effective against gastric and duodenal ulcers, reflux esophagitis, and Helicobacter pylori infections. The portfolio also features Humira, a fully human anti-TNF-alpha monoclonal antibody for autoimmune diseases like rheumatoid arthritis. Beyond prescription drugs, Eisai markets consumer health items such as Chocola BB Plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various third-class over-the-counter drugs, designated quasi-drugs, and food products with nutrient function. Originally founded in 1941 as Nihon Eisai Co., Ltd., the company adopted its current name, Eisai Co., Ltd., in 1955.
No. Eisai Co., Ltd. (ESALY) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. ESALY has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ESALY position with:
Real after-tax yield depends on where you live and how you hold ESALY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ESALY pays quarterly — 4 times per year. Ex-div: 2022-09-28.
How ESALY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ESALY sourced from FMP /financial-growth endpoint — real data, not estimates.
Compare ESALY with peers: ESALY vs AIHLF · ESALY vs CSWYF · ESALY vs IHHHF
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ESALY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Eisai Co., Ltd. (ESALY) is currently trading at $61.51, 17% below its 52-week high. It does not currently pay a regular dividend.
Eisai Co., Ltd. (ESALY) is a healthcare stock trading at $61.51. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever